Alfred Heart Centre, Alfred Hospital, Melbourne, Victoria, Australia.
J Cardiovasc Electrophysiol. 2013 Jul;24(7):742-51. doi: 10.1111/jce.12121. Epub 2013 Mar 14.
Pulmonary vein reconnection is a major limitation of pulmonary vein isolation (PVI) for symptomatic atrial fibrillation (AF). Adenosine may unmask dormant PV conduction and facilitate consolidation of PV isolation. We performed a systematic review of the literature to determine the impact of routine adenosine administration on clinical outcomes in patients undergoing PVI.
References and electronic databases reporting AF ablation and adenosine following PVI were searched through to 31 July 2012. Six studies included 544 patients to assess the impact of catheter ablation to target adenosine-induced PV reconnection on AF ablation outcome and 3 studies included 612 patients to assess the impact of adenosine testing on AF ablation outcome. Relative risks were calculated and combined in a meta-analysis using random effects modeling.
Routine adenosine testing for PV reconnection with additional targeted ablation resulted in a significant increase in freedom from AF post-PVI (RR 1.25; 95% CI 1.12-1.40; P < 0.001). However, within the group of patients undergoing adenosine testing, those with reconnection identified a population with a trend to reduction in freedom from AF despite the use of further targeted ablation in the reconnection group (RR 0.91 with 95% CI 0.81-1.03; P = 0.15).
Routine adenosine testing is associated with an improvement in freedom from AF post-PVI. Paradoxically acute adenosine-induced PV reconnection may portend a greater likelihood of AF recurrence despite additional ablation. Randomized controlled trials are required to determine the role of adenosine testing post-PVI.
肺静脉再连接是症状性心房颤动(AF)肺静脉隔离(PVI)的主要局限性。腺苷可能会揭示潜伏的 PV 传导,并有助于巩固 PV 隔离。我们对文献进行了系统回顾,以确定在接受 PVI 的患者中常规给予腺苷对临床结果的影响。
通过参考文献和电子数据库搜索截至 2012 年 7 月 31 日的 AF 消融术和 PVI 后腺苷的报告。有 6 项研究纳入了 544 例患者,以评估消融术靶向腺苷诱导的 PV 再连接对 AF 消融术结果的影响;3 项研究纳入了 612 例患者,以评估腺苷检测对 AF 消融术结果的影响。使用随机效应模型计算相对风险,并进行荟萃分析。
常规腺苷检测用于 PV 再连接,并进行额外的靶向消融,可显著提高 PVI 后无 AF 的自由度(RR 1.25;95%CI 1.12-1.40;P < 0.001)。然而,在接受腺苷检测的患者中,尽管在再连接组中进行了进一步的靶向消融,但发现再连接患者中无 AF 的自由度有降低趋势(RR 0.91,95%CI 0.81-1.03;P = 0.15)。
常规腺苷检测与 PVI 后无 AF 自由度的提高相关。矛盾的是,急性腺苷诱导的 PV 再连接可能预示着尽管进行了额外的消融,但 AF 复发的可能性更大。需要进行随机对照试验来确定 PVI 后腺苷检测的作用。